Inogen | INGN - Betriebsergebnis





Betriebsergebnis Veränderung Datum
Abbott USD 1.85B 399M 2026-03
Accuray USD 4.71M 6.86M 2024-12
AngioDynamics USD -2.51M 5.41M 2025-09
Artivion USD 4.79M 6.85M 2025-12
AtriCure USD 526K 1.96M 2026-03
Baxter International USD 66M 280.2M 2026-03
Becton, Dickinson and Co. USD 627M 36M 2026-03
Boston Scientific USD 1.05B 190M 2026-03
Chart Industries USD 52.6M 72.5M 2026-03
Cooper Companies USD 212.8M 72.4M 2025-12
Dexcom USD 255.3M 67.7M 2026-03
Edwards Lifesciences USD 514.7M 144.4M 2026-03
Globus Medical USD 164M 17.31M 2026-03
Inogen USD -7.79M 728K 2024-09
Insulet USD 122M 24.3M 2026-03
Masimo USD 77.4M 6.5M 2026-03
Medtronic USD 1.74B 40M 2025-12
Orthofix International USD 6.12M 1.91M 2025-12
Philips EUR 302M 417M 2026-03
ResMed USD 505.67M 8.07M 2026-03
Steris USD 318.7M 40.7M 2026-03
Stryker USD 1.1B 867M 2026-03
Tandem Diabetes Care USD 8.29M 31.16M 2025-12
Teleflex USD 37.03M 686K 2026-03
X T L Biopharmaceuticals USD -812K 48K 2024-12
Zimmer Biomet Holdings USD 395.1M 92.2M 2026-03